By Heritage Cannabis Holdings Corp. on Friday, 31 May 2019
Category: Vertically Integrated

Heritage Cannabis sign deal to work with Canntab Therapeutics

viewHeritage Cannabis Holdings Corp.

() President and CEO Clint Sharples and Canntab Therapeutics () CFO Richard Goldstein joined Christine Corrado from Proactive Investors New York to talk about their partnership that seems to really benefit both companies.

Heritage’s subsidiary Purefarma Solutions will provide
processing services for hemp supplied by Canntab, to their specification, as required for the production of Canntab’s planned ingestible oral cannabis products.

CSE:CANN

Market: CSE
Market Cap: $127.88 m
Follow

View company profile

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Heritage Cannabis Holdings Corp. named herein, including the promotion by the Company of Heritage Cannabis Holdings Corp. in any Content on the...

FOR OUR FULL DISCLAIMER CLICK HERE

Most read

Buds & Duds: Ontario's cannabis retail expansion plan gives cannabis stocks...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was 1.4% higher at 116.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF jumped 2.4% at C$9.55, while the OTCQX Cannabis index gained 0.6% to 434 points. Buds today are The Green...

on 12/13/2019

2 min read

Related Posts